Treating and elevating children with ASD poses an unlimited burden. Even though infantile autism has been first described by Leo Kanner (1) as early as 1943, yet the etiology of ASD isn’t utterly understood. The genetic background of ASD contains heterogenic traits (2) which might be described to be responsible for affecting the brain network signal conduction. However, causative remedy options are nonetheless not obtainable. The disease exhibits an increase in incidence with climbing numbers up to at least one out of 54 children (3). While progress has been made in establishing a psychological and symptom adapted therapy, the seek for biologic diagnostic parameters of the disease has turn out to be a significant matter in latest ASD research.
Several teams from Sweden, UK, and the USA offered helpful perception to grasp the genetic background and risk elements for ASD (4-8). While some teams postulate that ASD are extremely familial (7, 8), a remaining verdict on the underlying cause of ASD continues to be far away (2).
A milestone in ASD research was the discovering that ASD could also be induced by an interplay between genetic predisposition and immunological inflammatory elements (9-11). This changed paradigm of ASD conception opened the door to introduce biological (autologous or allogenic) stem cell therapies recognized amongst others for his or her immune-modulating properties (12, 13). On this context, an increasing variety of printed investigations reporting on treatment makes an attempt employing both autologous or allogeneic bone marrow (BM) or umbilical derived pluripotent cells (14-19) have encouraged us to report the results in a pilot group of children. Autologous BM-derived, level-of-care stem cell transplantation (SCT) was used as a result of the truth that it carries virtually no risk with respect to hostile autoimmune response and for its universal availability, because it doesn’t exclude kids with out stored umbilical cord or entry to umbilical cord blood.
Two studies applying intrathecal instillation of autologous stem cells had been reported by Sharma et al. (14) from India and Thanh et al. (15) from Vietnam in small cohorts. To start out a brand new procedure in a geographical and political part of the world as large because the EU in our opinion warrants the report of small case studies, which undoubtedly should and will probably be adopted by larger research in due time. Thus our intention was to contribute to the restricted expertise acquired so far by including two elements to the described operative protocol: specifically i.v. utility of stem cells and the transfusion of bone marrow derived plasma, known to be wealthy in cytokines, and development components.
All children received state-of-the-art, non-invasive treatment as steered by their specialists earlier than and after undergoing autologous, level-of-care SCT. For this retrospective case report, outcome was reported by the mother and father including the Autism Treatment Evaluation Checklist (ATEC) rating, which was completed online (https://www.autism.org/autism-remedy-analysis-guidelines/). The ATEC, a questionnaire developed by the Autism Research Institute (San Diego, CA) (6), is widely used in publications to describe changes over time. ATEC whole scores range from 0 to 179 points and are decided by adding up the four sections (part I (0-28 factors): speech/language/communication; part II (0-forty factors): sociability; section III (0-36 factors): sensory/cognitive awareness; and part IV (0-seventy five factors): well being/physical/conduct). A better rating signifies a higher stage of impairment.
The target analysis concerning progress and enhancements in ASD encounters quite a few difficulties. While there are already various diagnostic exams (e.g., Autism Diagnostic Observation Schedule, ADOS; Childhood Autism Rating Scale, Cars; Autism Diagnostic Interview – Revised, ADI-R), progress and enchancment are even harder to evaluate. Diagnostic checks, akin to ADOS, usually require specialists for execution and the take a look at per se was not developed to check for changes over time. Consequently, we determined to depend on the ATEC rating with all its limitations and advantages as has been performed in different publications in this discipline (16).
All SCTs had been carried out as level-of-care procedures in a class IIa operating room with sterile air movement. The following normal working process (SOP) was used: (1) anesthesia was prepared with rectal administration of Midazolam (1mg/kg physique weight with max. of 15mg); (2) slowly starting sedation with 5-8ml (i.v.) 1%-Propofol (sedoanalgesia); (3) positioning of the patient on one side following surgical washing and draping the anterior and posterior iliac crest; (4) injection of 2ml of 1%-Xylocaine at the planned puncture websites on the periosteum and subcutaneously; (5) aspiration of BM from the posterior and anterior iliac crest followed by a switch of the BM aspirate to a sterile blood bag; (6) the BM aspirate was then processed in the operating room in accordance with the proprietary protocol using a fully automated cell separator (Sepax S-100; Biosafe S.A., Eysins, CH); (7) after lumbar puncture of the dural sac 2ml of cerebral spinal fluid (CSF) was routinely withdrawn in order to stop high intrathecal stress secondary to injection of the stem cell concentrate; (8) intrathecal administration of the obtained BM focus (~1ml/10kg physique weight); and (9) i.v. administration of the remaining BM focus and plasma supernatant (10). Standard postoperative care was applied.
Samples of BM aspirate/CSF and focus have been transferred to the identical laboratory instantly after SCT and had been analyzed with fluorescence activated cell sorter (FACS) utilizing a stem cell kit from Beckman Coulter and the ISHAGE protocol (https://www.bc-cytometry.com/PDF/DataSheet/IM3630.pdf). Stem cell counts together with CD34+ and CD45+/leukocytes, which are generally known as oblique indicators for progenitor cells, had been obtained to quantify stem cells.
A summary of demographic, diagnostic, and laboratory information and stem cell transplantation particulars of the 4 kids with ASD are introduced in Table 1.
Table 1. Demographic, diagnostic, and laboratory knowledge and stem cell transplantation particulars of the 4 children with autism spectrum disorder (ASD).
Case Description
Case #1
The delivery, a deliberate caesarean part in the 38th week of pregnancy, of a boy from a 40-year-outdated healthy mom and a 41-year-old healthy father, went without complications. The beginning body weight and length had been 3340g and 51cm, respectively. The youngster developed normally, like his older brother, until the age of two years. Thereafter, the mother and father observed that the boy step by step misplaced the vocabulary he had already acquired with out comorbidity. At 2.5 years of age the child was non-verbal; thus, speech therapy was started. Since the speech therapy showed no success after about 1.5 years of implementation, the boy was evaluated in a particular clinic for psychiatry and diagnose with autism by Autism Diagnostic Observation Schedule (ADOS) ASD on the age of 4-years.
Immediately after the diagnosis, the baby started the so-called ABA (Applied Behavior Analysis) therapy at dwelling (3h/day). Drug therapy with Atomoxetine (8mg oral/day), Risperidone (1mg/ml from 0.5 to 2 x 0.5ml/day), and Cerebrolysin® injection 2 x 2.5ml/week was not started till 6 months after diagnosis. Despite average cognitive improvements, there was no change in speech according to the mother and the baby was weaned from all remedy. Finally, the mother and father decided to let the child undergo autologous SCT in our center.
The boy confirmed no minor or serious uncomfortable side effects. The mother and father observed first impressions of a benefit of the SCT at the 3 months comply with-up assessment. After a yr the little one improved mainly relating to speech (e.g., the little one began to formulate simple sentences with several phrases, to ask significant questions, and at last to have conversations), social conduct (e.g., he showed better eye contact, obeyed higher, and had no more tantrums), and also habits relating to meals intake and hyperactivity. All available, parents-generated ATEC scores are introduced in Figure 1A.
Figure 1. Autism therapy analysis checklist (ATEC) scores of (A) case #1, (B) case #2, (C) case #3, and (D) case #four earlier than and after stem cell Children’s stem cell transplantation (SCT).
Case #2
The one youngster of a wholesome 25-year-old mom and a wholesome 31-12 months-outdated father was born in the 39th week of pregnancy via caesarean section as a result of umbilical cord malposition around the neck of the baby. The delivery weight was 3600g and the body length 51cm. The first signs of an ASD (e.g., didn’t respond to call, reveals little eye contact) were already apparent in the first 12 months of life. At the age of three the boy was then diagnosed as autistic (F84.0) by a neuropsychiatrist. Dyspraxia (F82) was also discovered. Drug treatment with Cerebrolysin® injection 1-5ml/week, in addition to habits therapy (2h/day) was utilized as really useful by the specialist for a couple of years. On the age of 7.5, the language improvement was retarded to the extent of a three yr outdated little one. Based on suggestions BM-derived SCT of and exchanges with other parents, the boy’s dad and mom determined to have their son handled with autologous SCT.
The little one had no minor or severe negative effects. Parents noticed vital behavioral adjustments regarding hyperactivity, inflexible habits, but in addition enhancements with original digestive problems, sensitivity to noise, and anxiety 9 months after the autologous SCT. Significant behavioral adjustments concerning hyperactivity, inflexible habits, but in addition improvements with original digestive problems, sensitivity to noise, and anxiety have been reported by the mother and father 9 months after the autologous SCT. All out there, parents-generated ATEC scores are offered in Figure 1B.
Case #3
The boy was born as a single little one to a 30-yr-old healthy mother and a 35-year-outdated wholesome father by way of caesarean section as a consequence of umbilical cord malpositioning across the neck. The beginning physique weight was 4,000g. The mom noticed that her baby boy confirmed hardly any eye contact, did not react to names, and showed hardly any social interplay. However, a definitive prognosis of ASD was made by a psychiatrist later on at the age of three years. The little one lagged correct speech growth; based on the dad and mom, he understands everything, however cannot categorical himself. He was not handled with any drugs nor behavioral therapy as suggested by his physicians. The choice of the mother and father to go for autologous SCT was made on the boy’s age of 14.5 years and was also primarily based on personal communication with different parents.
The boy showed no minor or critical negative effects. Despite the advanced age, linguistic (e.g., he started to speak two-phrase sentences) and especially sensory enhancements akin to perceiving and reacting to the environment have been observed by the parents. All out there, mother and father-generated ATEC scores are offered in Figure 1C.
Case #4
The one lady in this case collection was born because the little sister of a 2-12 months older boy to a 34-yr-outdated healthy mother and a 31-12 months-outdated healthy father via an elective caesarean part at the 38th week of pregnancy. The birth weight was 3,180g and the physique size 50cm. The girl developed normally, like his older brother, till the age of 1.5 years, thereafter the mother and father observed that her conduct was not the identical as the older sibling (e.g., she was not reacting when referred to as, no eye contact, not speaking, and she all the time wished to be left alone). With 18 months the youngster was diagnosed as autistic by a neurologic pediatrician. Additionally, the lady was diagnosed with bronchial asthma requiring inhalation therapy. Immediately after analysis, the child started ABA, which included 3h/day with a specialized psychotherapist and the remaining time ABA was continued together with her mom. Because of only slight enhancements with 2-years of ABA therapy, the parents determined to let the child undergo autologous SCT. Deficits existed primarily regarding speaking, frustration, and concentration.
SCT was performed without any minor or main complications. Three months after the SCT, the girl showed improved initiative and learning habits and was even in a position to recollect the realized matter. Furthermore, she has no asthma anymore and the numbers of colds she used to have, significantly decreased. All obtainable, parents-generated ATEC scores are introduced in Figure 1D.
Furthermore, parents reported that they had been very a lot glad (Case #1 and Case #3) or a lot satisfied (Case #2 and Case #4) with the procedure and that they might endure SCT again. This satisfaction correlates with the ATEC score. Considering an ATEC whole rating between 31 and 50 factors as a reasonable type of ASD and values beneath 30 factors as a mild kind, then ASD all instances modified from average to mild form of ASD probably in relation to autologous SCT (Figures 1A-D). No relapse has been observed thus far (1-2 years).
Discussion
With this report we present promising outcomes concerning security and efficacy suggesting utility of autologous, BM-derived, intrathecally and simultaneously intravenously utilized, point-of-care SCT in four children with ASD.
Immediate and Delayed Complications
Using sedation and native anesthesia, the procedure involving BM-biopsy and intrathecal instillation of remoted and concentrated BM stem cells resulted in no speedy or delayed minor or major adversarial events. That is more than likely attributed to stringent condition present in the operation theatre and experience of the surgeon and anesthetist. The post-operative course throughout the following 48h was uneventful too as preventive non-steroidal anti-inflammatory drug pre-medication and anti-emetics were prescribed.
Sharma et al. (14) in a bunch of 34 children reported asides minor negative effects together with nausea, vomiting, and native ache, a share of main adverse occasions in 31% (10/32) comprising hyperactivity and epileptic seizures. Thanh et al. (15) reported no main antagonistic event in similarly sized research on 30 youngsters undergoing repeated interventions. In our pilot research we encountered neither rapid, nor delayed major hostile occasions.
Assessment of Treatment Outcome
In our small series, remedy consequence reported over a comply with-up interval of 1-1.5 year relied on the suggestions of the dad and mom and ATEC rating. We’re aware that dad and mom reporting consequence is subject to bias and to a sure extent on behavioral non-compliance of the kids, in our context and much like a randomized managed trial using ATEC as primary endpoint (16), parental-reported ATEC proved to be dependable to assess longitudinal outcome.
Despite the presence of professional ranking instruments akin to ADOS, Cars, and ADI-R to diagnose and evaluate ASD, such tools may have disadvantage in each day follow. As well as, the dependency on numerous sources to acquire a more complete clinical image has been advocated (17).
Diagnostic checks are principally not well suited to judge adjustments over time and as such do require specialists for execution. Especially in patients with ASD and day by day fluctuations, parental assessment with their steady observation of behavioral and developmental modifications, could also be a serious benefit to single time point assessments.
However, one confounder is that neither standardized test nor parental observations can account for the inherent nature of Ads signs and their improvements over time. In our series, the enrolment of the youngsters to endure the SCT process was motivated by the frustration of parents a earlier lack of improvement.
Efficacy of the Procedure
Following SCT, reported ATEC scores revealed significant enhancements in all ATEC subgroups including speech/communication, social habits, sensory/cognitive awareness, well being/physical/habits in comparison with pretreatment standing. Such amelioration not only improved the rapid high quality of life of the youngsters and their atmosphere, but may contribute to the kids’s future means to conduct an independent life in a protected atmosphere. Hence, from an economical standpoint, such improvements may result in important reductions of continuously incurring care prices with age.
Comparable to our treatment approach applying autologous BM-derived intrathecally applied SCT, two investigations -one applying a single (14) and the opposite two- intrathecal (15) stem cell instillations additionally reported encouraging results. Mixed results have been reported using intravenous delivery of both, autologous or allogenic, umbilical cord blood-derived SCT. Two studies reported vital enhancements (18, 19), while the remaining two solely a trend in the direction of enchancment in a sub-evaluation in children without intellectual incapacity (20, 21). Details hereto are summarized in Table 2. Intrathecal utility was favored by us on these clinical and also theoretical grounds. Stem cells are too massive to cross the blood brain barrier, hence, they have to be applied instantly into the CSF via intrathecal route in order to achieve the mind.
Table 2. Published investigations reporting intrathecal or intravenous application of both autologous or allogenic stem cell transplantation for youngsters with autism spectrum disorder (ASD).
An necessary element reported while interviewing the mother and father was that children started to respond significantly better and quicker to their speech and behavior therapy 3-6 months following SCT. Published information suggest that SCT reduces the immunological inflammatory disease of the mind associated with ASD and thus, opens the door for effectiveness of ABA and speech therapy. Indeed, a recent proteomic analysis study discovered nine serum proteins to be considerably different in ASD compared to sometimes developing boys and a significant correlation with ASD severity in accordance with ADOS (24). Possible mechanisms for the way in which stem cells improve autism have been mentioned more extensively by Liu et al. (25). In abstract, two mechanisms seem to prevail: (a) reset of the immunological system and (b) improved vascular perfusion of the brain, two mechanisms which can be addressed both by the stem cells but additionally by the bone marrow plasma, rich in progress hormones.
There is a big body of knowledge pointing at immune-related genetically coupled risk factors and occasions associated with ASD. A cascade of events, leading disruption of neuronal maturation and dysfunctional networking by way of dysfunctional astrocytic neuronal help. A complete evaluate on this subject was just lately printed by Liu et al. (25). More interestingly, neuropathological investigations have recently provided proof in help of the inflammatory principle, describing perivascular lymphocytic infiltration within the cerebral white, grey matter, and neuronal leptomeninges, this infiltrates had been quantitatively accompanied by a corresponding magnitude of astrocytic activation in the affected regions of the mind. As well as they reported vital loss on neurons and glial cells of the cerebral gray matter immediately adjoining to the leptomeningeal area. Brain micropathology also concerned periventricular and other cerebral spinal fluid brain interfaces and vascular ependymal constructions, all contributing to a purposeful disruption of the blood brain barrier (26, 27).
However, in ASD it seems that the overexpression of particular histocompatibility (HLA) genes (chromosome 6) and notably activating KIR genes (chromosome 19) play an vital position in promoting the cellular autoimmune cascade in mind tissue (28). The overexpression of the genes as in comparison with the general inhabitants offers a molecular foundation for understanding occasions triggering a pathological immune response to viral or microbial antigens. BM-derived SCT is able to targeting these pathological processes within the brain with out having immediate and mid-term hostile events. The longevity of the impact of BM-derived SCT on suppressing inflammation and derailed autoimmune processes in the central nervous system (29) requires further investigations in bigger cohorts. Furthermore, it is speculated if repeated therapy might have a cumulative impact on ASD. As well as, lengthy-term commentary are needed in kids following autologous BM-derived SCT, though low chance, to rule out potential undesirable complications. Addition points that require additional elucidation contain (a) the efficacy and safety of employed cell sorts i.e., allogenic vs. autologous, umbilical cord-derived vs. autologous BM-derived, (b) the route of administration (intravenous vs. intrathecal), and (c) the added worth of injecting BM-derived plasma. Presently, the quite restricted available literature indicates more favorable results when employing intrathecal over intravenous route, most likely because with the later, many of the cells will likely be filtered by the lung parenchyma during their first blood passage.
Autologous SCT have a biological benefits over allogenic stem cells and resemble a novel and promising remedy option for autistic youngsters and adolescent not benefiting from typical symptom-based mostly and behavioral therapy. In ASD affected kids providing intrathecal SCT at an earlier age must be associated with the next profit, because the brain plasticity and neurogenesis are at their maximum (30, 31), while perivascular damage to the neuronal circuitry is minimal.
Previous findings point out that autologous, BM-derived, intrathecally and concurrently intravenously utilized, point-of-care SCT is a protected therapeutic option by exhibiting no adversarial occasions. Furthermore, our findings additionally confirmed improvements in all four ATEC subsets together with speech/communication, social behavior, sensory/cognitive consciousness and well being/bodily conduct. Our and previous outcomes by other authors are promising, but mandate additional investigations in a bigger managed cohort of patients together with objective strategies resembling biomarkers to probably higher understand the underlying individual dysfunction and potentially permit a stratification of these patients who might profit most from this therapy strategy.
Data Availability Statement
The unique contributions introduced within the examine are included in the article/supplementary materials, further inquiries may be directed to the corresponding author/s.
Ethics Statement
Ethical assessment and approval was not required for the examine on human individuals in accordance with the native laws and institutional requirements. Written knowledgeable consent to participate in this examine was offered by the members’ legal guardian/next of kin. Written informed consent was obtained from the individual(s), and minor(s)’ authorized guardian/subsequent of kin, for the publication of any probably identifiable photos or knowledge included in this article.
Author Contributions
GK and BL: wrote the primary draft of the manuscript and coordinated and supervised information collection. GK: an experienced normal and cardiac surgeon, carried out all SCTs. GK, JZ, CP, and BL: substantially contributed to interpretation of information for the work and critically reviewed and revised the manuscript for vital mental content material. All authors gave their final approval and agreed to be accountable for all features of this work ensuring its integrity and accuracy.
Conflict of Interest
The authors declare that the analysis was carried out in the absence of any business or monetary relationships that could be construed as a potential battle of interest.
Publisher’s Note
All claims expressed in this article are solely these of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that could be evaluated in this text, or claim that could be made by its producer, is just not assured or endorsed by the publisher.
Acknowledgments
We gratefully acknowledge the participation of the mother and father and for allowing us to be taught from their tales. We want to thank the anesthetist for his excellent performance in pediatric anesthesia main to attenuate any postoperative unwanted side effects.
1. Kanner L. Autistic disturbances of affective contact. Nerv Child. (1943) 2:217-50.
2. Robinson EB, Neale BM, Hyman SE. Genetic analysis in autism spectrum disorder. Curr Opin Pediatr. (2015) 27:685-91. doi: 10.1097/MOP.0000000000000278
3. Maenner MJ, Shaw KA, Baio J, Washington A, Patrick M, DiRienzo M, et al. Prevalence of autism spectrum disorder among kids aged eight years – autism and developmental disabilities monitoring community, eleven sites, United States. MMWR. (2020) 69:1-12. https://www.cdc.gov/mmwr/volumes/69/ss/ss6904a1.htm?s_cid=ss6904a1_w (accessed September 20, 2021).
4. Lichtenstein P, Carlstrom E, Rastam M, Gillberg C, Anckarster H. The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am J Psychiatry. (2010) 167:1357-63. doi: 10.1176/appi.ajp.2010.10020223
5. Roland A, Happe F, Price TS, Baron-Cohen S, Polmin R. Phenotypic and genetic overlap between autistic traits and their extremes of the general population. J Am Acad Child Aadolesc Psychiatry. (2006) 45:1206-14. doi: 10.1097/01.chi.0000230165.54117.41
6. Constantino JN, Todd RD. Autistic traits in the overall population: a twin examine. Arch Gen Psychiatry. (2003) 60:524-30. doi: 10.1001/archpsyc.60.5.524
7. Constantino JN, Todorov A, Hilton C, Law P, Zhang Y, Molloy E, et al. Autism recurrence in half siblings: sturdy assist for genetic mechanisms of transmission in ASD. Mol Psychiatry. (2013) 18:137-8. doi: 10.1038/mp.2012.9
8. Constantino JN, Zhang Y, Frazier T, Abbacchi AM, Law P. Siblings recurrence and the genetic epidemiology of artisan. Am J Psychiatry. (2010) 167:1349-56. doi: 10.1176/appi.ajp.2010.09101470
9. Gesundheit B, Rosenzweig JP, Naor D, Lerer B, Zachor DA, Prochazka V, et al. Immunological and autoimmune concerns of autism spectrum disorders. J Autoimmun. (2013) 44:1-7. doi: 10.1016/j.jaut.2013.05.005
10. Gesundheit B, Rosenzweig JP. Editorial: autism spectrum disorders (ASD)-looking for the biological basis for behavioral symptoms and new therapeutic targets. Front Neurosci. (2016) 10:607. doi: 10.3389/fnins.2016.00607
11. Gesundheit B, Ashwood P, Keating A, Naor D, Melamed M, Rosenzweig JP. Therapeutic properties of mesenchymal stem cells for autism spectrum disorders. Med Hypotheses. (2015) 84:169-77. doi: 10.1016/j.mehy.2014.12.016
12. Zhao Y, Huang Z, Qi M, Lazzarini P, Mazzone T. Immune regulation of T lymphocyte by a newly characterized human umbilical cord blood stem cell. Immunol Lett. (2007) 108:78-87. doi: 10.1016/j.imlet.2006.10.007
13. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in well being and illness. Nat Rev Immunol. (2008) 8:726-36. doi: 10.1038/nri2395
14. Sharma A, Gokulchandran N, Sane H, Nagrajan A, Paranjape A, Kulkarni P, et al. Autologous bone marrow mononuclear cell therapy for autism: an open label proof of idea study. Stem Cells Int. (2013) 2013:623-875. doi: 10.1155/2013/623875
15. Thanh LN, Nguyen H-P, Ngo MD, Bui VA, Dam PTM, Bui HTP, et al. Outcome of bone marrow mononuclear cell transplantation combined with interventional training for autis spectrum disorder. Stem Cells Trans Med. (2021) 10:14-26. doi: 10.1002/sctm.20-0102
16. Whitehouse AJO, Granich J, Alvares G, Busacca M, Cooper MN, Dass A, et al. A randomized controlled trial of an iPad-primarily based utility to complement early behavioural intervention in autism spectrum disorder. J Child Psychol Psychiatry. (2017) 58:1042-52. doi: 10.1111/jcpp.12752
17. de Bild A, Oosterling IJ, van Lang NDJ, Systema S, Mideraa RB, van England H, et al. Standardized ADOS scores: measuring severity of autism spectrum disorders in Dutch samples. J Autism Dev Disord. (2011) 41:311-9. doi: 10.1007/s10803-010-1057-0
18. Lv YT, Zhang Y, Liu M, Qiuwaxi JN, Ashwood P, Cho SC, et al. Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. J Transl Med. (2013) 11:196. doi: 10.1186/1479-5876-11-196
19. Dawson G, Sun JM, Davlantis KS, Murias M, Franz L, Troy J, et al. Autologous cord blood infusions are protected and feasible in young children with autism spectrum disorder: outcomes of a single-center section I open-label trial. Stem Cells Transl Med. (2017) 6:1332-9. doi: 10.1002/sctm.16-0474
20. Chez M, Lepage C, Parise C, Dang-Chu A, Hankins A, Carroll M. Safety and observations from a placebo-managed, crossover examine to assess use of autologous umbilical cord blood stem cells to enhance symptoms in youngsters with autism. Stem Cells Transl Med. (2018) 7:333-41. doi: 10.1002/sctm.17-0042
21. Dawson G, Sun JM, Baker J, Carpenter K, Compton S, Deaver M, et al. A section II randomized clinical trial of the safety and efficacy of intravenous umbilical cord blood infusion for remedy of youngsters with autism spectrum disorder. J Pediatr. (2020) 222:164-73. doi: 10.1016/j.jpeds.2020.03.011
22. Sharifzadeh N, Ghasemi A, Afshari JT, Moharari F, Soltanifar A, Talaei A, et al. Intrathecal autologous bone marrow stem cell therapy in kids with autism: a randomized managed trial. Asia Pac Psychiatry. (2021) 13:e12445. doi: 10.1111/appy.12445
23. Sharma AK, Gokulchandran N, Kulkarni PP, Sane HM, Sharma R, Jose A, et al. Cell transplantation as a novel therapeutic strategy for autism spectrum disorders: a clinical research. Am J Stem Cells. (2020) 9:89-100.
PubMed Abstract | Google Scholar
24. Hewitson L, Mathews JA, Devlin M, Schutte C, Lee J, German DC. Blood biomarker discovery for autism spectrum disorder: a proteomic analysis. PLoS ONE. (2021) 16:e0246581. doi: 10.1371/journal.pone.0246581
25. Liu Q, Chen MX, Sun L, Wallis CU, Zhou JS, Ao LJ, et al. Rational use of mesenchymal stem cells in the remedy of autism spectrum disorders. World J Stem Cells. (2019) 11:55-72. doi: 10.4252/wjsc.v11.i2.55
26. Di Stasio MM, Nagakura I, Nadler MJ, Andreson MP. T-lymphocytes and cytotoxic astrocytic blebs correlate throughout autism brain. Ann Neuro. (2019) 86:885-98. doi: 10.1002/ana.25610
27. Chaudhuri Ad, Dasgheyb RM, DeVine LR, Bi H, Cole RN, Haughey NJ. Stimulus-dependent modifications in astrocyte-derived extracellular vesicle cargo regulate neuronal excitability. Glia. (2020) 68:128-44. doi: 10.1002/glia.23708
28. Torres AR, Sweeten TL, Cutler A, Bedke BJ, Fillmre M, Stubbs EG, et al. The affiliation and linkage of the HLA-A2 class I allele with autism. Hum Immunol. (2006) 67:346-51. doi: 10.1016/j.humimm.2006.01.001
29. Pardo CA, Farmer CA, Thurm A, Shebl FM, Ilieva J, Kalra S, et al. Serum and cerebrospinal fluid immune mediators in youngsters with autistic disorder: a longitudinal examine. Mol Autism. (2017) 8:1. doi: 10.1186/s13229-016-0115-7
30. Eriksson PS, Perfilieva E, Björk-Eriksson T, Alborn AM, Nordborg C, Peterson DA, et al. Neurogenesis in adult human hippocampus. Nat Med. (1998) 4:1313-7. doi: 10.1038/3305
PubMed Abstract | CrossRef Full Text | Google Scholar
31. Knoth R, Singec I, Ditter M, Pantazis G, Capetian P, Meyer RP, et al. Murine options of neurogenesis within the human hippocampus throughout the lifespan from 0 to 100 years. PLoS ONE.
If you have any concerns pertaining to where and ways to utilize https://autismtreatmentcare.com/, you could contact us at our internet site.